Biim is a global medical company developing low-cost portable and pocketable ultrasound devices that connect to IOS and Android interfaces. Biim is entering the commercial stage with both FDA and CE approvals in place. The company has signed a 3-year distr. agreement with AngioDynamics worth a minimum of 20 million USD. Year-to-date revenue has exceeded more than 2.4 million USD. The company has secured a credit facility of 4 million USD with DNB. Biim is raising up to 9 million USD for the development of two new probes and to expand the global footprint to more than 30 countries.